Assessing the landscape and charting paths : UK neurology trainees' opinions on neuroinflammation subspecialty
Arun, Tarunya Petheram, Kate Tallantyre, Emma Ford, Helen Chataway, Jeremy Dougall, Niall Mac Doshi, Anisha Englezou, Christina Farrell, Rachel Hughes, Stella
Arun, Tarunya
Petheram, Kate
Tallantyre, Emma
Ford, Helen
Chataway, Jeremy
Dougall, Niall Mac
Doshi, Anisha
Englezou, Christina
Farrell, Rachel
Hughes, Stella
Citations
Altmetric:
Affiliation
Arun T, Petheram K, Tallantyre E, Ford H, Chataway J, Dougall NM, Doshi A, Englezou C, Farrell R, Hughes S, Donnell GM, Murray K, Rees R, Robertson N, Schmierer K, Dobson R; Association of British Neurologists, Special interest group for MS and neuroinflammation
Other Contributors
Publication date
2024-11-10
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
Therapeutics of neuroinflammatory disorders including multiple sclerosis is one of the fastest growing areas in neurology. However, pressures on higher specialty training in neurology together with an expanding curriculum have led to challenges in adequately preparing trainees for a subspecialist career. In this study we set out to understand current perceptions and barriers to training in neuroinflammatory disorders among neurology trainees in the UK. A structured questionnaire was used to assess trainees' perspectives on training opportunities and career aspirations. Findings reveal significant gaps in training, including insufficient training opportunities, lack of mentorship, and concerns about managing complex treatment regimes. We used these findings to develop structured action points with aim of improving training and retention in this subspecialty. These include early exposure to subspecialty experiences, enhanced mentorship, and equal access to training opportunities regardless of geographical location. Our findings underscore the need for further curriculum development in neurology training, potentially combining early support with dedicated fellowships later in training, in order to ensure sustainability of neuroinflammation as a subspecialty and to meet the growing demand for expertise in MS and related conditions.
Citation
Mult Scler Relat Disord. 2024 Nov 10;92:106144.
Type
Article